Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disor... von Mischoulon, D., Hylek, L., Yeung, A.S., Clain, A.J., Baer, L., Cusin, C., Ionescu, D.F., Alpert, J.E., Soskin, D.P., Fava, M.

Volltext